Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/05/2000 | CA2368374A1 47 human secreted proteins |
10/05/2000 | CA2368302A1 49 human secreted proteins |
10/05/2000 | CA2368281A1 50 human secreted proteins |
10/05/2000 | CA2368234A1 Method of affecting cholesterol catabolism using nuclear bile acid receptor |
10/05/2000 | CA2368233A1 Recombinant neospora antigens and their uses |
10/05/2000 | CA2368216A1 Novel guanosine triphosphate (gtp)-binding protein-coupled receptor proteins, bg3 |
10/05/2000 | CA2368119A1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus |
10/05/2000 | CA2368113A1 Protozoan expression system |
10/05/2000 | CA2368040A1 Ku80 homolog and uses thereof |
10/05/2000 | CA2368014A1 Casb619 involved in colon cancers |
10/05/2000 | CA2367999A1 Polypeptides having branching enzyme activity and nucleic acids encoding same |
10/05/2000 | CA2367989A1 Diagnosis of whipple disease |
10/05/2000 | CA2367901A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
10/05/2000 | CA2367826A1 Process for partitioning of proteins |
10/05/2000 | CA2367424A1 Hookworm platelet inhibitor |
10/05/2000 | CA2366604A1 Modulators of polysaccharides and uses thereof |
10/05/2000 | CA2366459A1 Universal arrays |
10/05/2000 | CA2366305A1 Method for expressing proteins |
10/05/2000 | CA2365728A1 Attenuated dengue-1 virus vaccine |
10/05/2000 | CA2365635A1 Transducing phages |
10/05/2000 | CA2365601A1 Novel cytidine deaminase |
10/05/2000 | CA2365596A1 Compositions and methods for the modification of gene expression |
10/05/2000 | CA2365594A1 Microbiological production method for .alpha.-l-aspartyl-l-phenylalanine |
10/05/2000 | CA2365411A1 Attenuated dengue-2 virus vaccine |
10/05/2000 | CA2365297A1 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection |
10/05/2000 | CA2364417A1 Peroral gene therapy of diabetes and obesity |
10/05/2000 | CA2364305A1 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
10/05/2000 | CA2363716A1 49 human secreted proteins |
10/05/2000 | CA2361408A1 Schizophrenia associated genes, proteins and biallelic markers |
10/05/2000 | CA2334707A1 Pseudo-cyclic oligonucleobases |
10/05/2000 | CA2329261A1 Susceptibility to psoriasis |
10/05/2000 | CA2329122A1 Exonuclease-mediated nucleic acid reassembly in directed evolution |
10/04/2000 | EP1041158A2 Method for quantification of an analyte |
10/04/2000 | EP1041152A1 Retroviral vectors |
10/04/2000 | EP1041151A1 Luciferase and method for assaying intracellular atp by using the same |
10/04/2000 | EP1041150A1 Hybrid synthetase, fungus/bacterium strain, hybrid peptide and compositions containing same |
10/04/2000 | EP1041149A2 Vaccine and antitoxin for treatment and prevention of C. difficile disease |
10/04/2000 | EP1041148A1 Pathogen inducible promoter |
10/04/2000 | EP1041147A2 Microtubule-associated protein TPX2 |
10/04/2000 | EP1041146A1 Tumor antigen protein, gene thereof, and utilization thereof |
10/04/2000 | EP1041145A2 Oligonucleotides labeled with stable isotopes and a method for detecting the same |
10/04/2000 | EP1041144A1 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection |
10/04/2000 | EP1041143A2 A method for identification of biologically active peptides and nucleic acids |
10/04/2000 | EP1041142A2 Universal donor cells |
10/04/2000 | EP1040352A1 Solid-phase tips and uses relating thereto |
10/04/2000 | EP1040351A1 C-terminal region of agouti-related transcript (art) protein |
10/04/2000 | EP1040203A1 Nucleic acid ligand diagnostic biochip |
10/04/2000 | EP1040202A1 Dna polymorphism identity determination using flow cytometry |
10/04/2000 | EP1040201A1 Single chain monoclonal antibody fusion reagents that regulate transcription in vivo |
10/04/2000 | EP1040200A1 Virulence-associated nucleic acid sequences and uses thereof |
10/04/2000 | EP1040198A1 Recombinant rhabdovirus containing a heterologous fusion protein |
10/04/2000 | EP1040197A1 A process for site-directed integration of multiple copies of a gene in a mould |
10/04/2000 | EP1040196A2 Transgenic animal model for degenerative diseases of cartilage |
10/04/2000 | EP1040195A2 Regulatory dna sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof |
10/04/2000 | EP1040194A1 Human signal transduction serine/threonine kinase |
10/04/2000 | EP1040193A1 Promoter from ashbya gossypii |
10/04/2000 | EP1040192A1 Insect-resistant transgenic plants and methods for improving delta-endotoxin activity against insects |
10/04/2000 | EP1040191A2 Rantes mutants and therapeutic applications thereof |
10/04/2000 | EP1040190A1 Serine proteinase inhibitors |
10/04/2000 | EP1040189A1 Polypeptides, their production and use |
10/04/2000 | EP1040188A2 HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND cDNAS ENCODING THESE PROTEINS |
10/04/2000 | EP1040187A2 Human protein kinase and kinase inhibitors |
10/04/2000 | EP1040186A2 Fusion proteins for use in enzymatic synthesis of oligosaccharides |
10/04/2000 | EP1040185A2 Neural precursor cells, method for the production and use thereof in neural defect therapy |
10/04/2000 | EP1040184A1 HIGH EXPRESSION $i(ESCHERICHIA COLI) EXPRESSION VECTOR |
10/04/2000 | EP1040183A1 Nucleic acid encoding mammalian ubr1 |
10/04/2000 | EP1040126A2 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells |
10/04/2000 | EP1040125A1 Glucose regulated gene |
10/04/2000 | EP1040124A1 Novel abc transporter |
10/04/2000 | EP1040123A2 Human papillomavirus vaccine |
10/04/2000 | EP1040122A1 Protein binding polypeptides |
10/04/2000 | EP1040118A1 Secreted proteins and polynucleotides encoding them |
10/04/2000 | EP1040117A1 110 human secreted proteins |
10/04/2000 | EP1040116A1 Functionalized pyrimidine derivatives |
10/04/2000 | EP1039972A1 Method and device for production of components for microfabrication |
10/04/2000 | EP1039935A1 USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
10/04/2000 | EP1039934A1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
10/04/2000 | EP1039930A2 Adjuvanted vaccine formulation |
10/04/2000 | EP1039929A1 Activated t-cells and their uses |
10/04/2000 | EP1039927A1 UGC (UPSTREAM GENE OF cdsA) |
10/04/2000 | EP1039923A1 Gamma-conopeptides |
10/04/2000 | EP0821583B1 Dna vaccines against rotavirus infections |
10/04/2000 | EP0774118B1 Target specific screens and their use for discovering small organic molecular pharmacophores |
10/04/2000 | EP0699236B1 Purified mammalian flt3 ligands and agonists and antagonists thereof |
10/04/2000 | EP0479870B1 A mutated subtilisin protease |
10/04/2000 | CN1268980A Novel screening methods to identify agents that selectively inhibit hepatitis C virus replication |
10/04/2000 | CN1268979A Multiple functionilities within an array element and uses thereof |
10/04/2000 | CN1268978A High specificity homocysteine assays for biological samples |
10/04/2000 | CN1268976A Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same |
10/04/2000 | CN1268975A DNA polymerase-related factors |
10/04/2000 | CN1268974A Tolerance of trichothecene mycotoxins in plants and animals through the modification of the ribosomal protein L3 gene |
10/04/2000 | CN1268973A Beta-amyloid peptdie-binding proteins and polynucleotides encoding the same |
10/04/2000 | CN1268954A method and compositions for treating abnormal cell growth relating to unwanted guanine nucleotide exchange factor activity |
10/04/2000 | CN1268953A Ligand for herps simplex virus entry mediator and method of use |
10/04/2000 | CN1268575A Oligonucleotide primer effective with multiple detection of hepatitis C virus (HCV) and human immunologic deficiency virus (HIV) |
10/04/2000 | CN1268573A Carrier for expressing Chiense chicken pox virus vaccine strain |
10/04/2000 | CN1268572A Method for synthesizing 5-enol pyruvoyl-shikimic acid-3-phosphoric acid synthetase gene |
10/04/2000 | CN1268571A New human ribosomal subunit protein and its coding sequence |
10/04/2000 | CN1268570A New human ribosomal subunit protein and its coding sequence |
10/04/2000 | CN1268569A New human triglyceride lipase precursor protein and its coding sequence |